Master the CAMLPR Transfusion Test with interactive questions and detailed explanations. Boost your knowledge and ensure you're exam-ready with comprehensive study resources!

Multiple Choice

Which statement best describes the AHG phase significance in antibody testing?

The AHG phase reveals antibodies that have already attached to red cells during testing by using anti-human globulin to bridge the bound antibodies. This highlights IgG antibodies, which are the ones most likely to cause clinically significant problems such as transfusion reactions or hemolytic disease of the fetus and newborn. IgM antibodies are typically detected earlier (immediate spin) and are not as often associated with transfusion complications, so they are not the focus of the AHG phase. By identifying these clinically significant alloantibodies, the AHG step is essential in compatibility testing. While autoantibodies can be detected at this phase as well, the primary clinical relevance is uncovering antibodies that could harm a transfusion recipient.

The AHG phase reveals antibodies that have already attached to red cells during testing by using anti-human globulin to bridge the bound antibodies. This highlights IgG antibodies, which are the ones most likely to cause clinically significant problems such as transfusion reactions or hemolytic disease of the fetus and newborn. IgM antibodies are typically detected earlier (immediate spin) and are not as often associated with transfusion complications, so they are not the focus of the AHG phase. By identifying these clinically significant alloantibodies, the AHG step is essential in compatibility testing. While autoantibodies can be detected at this phase as well, the primary clinical relevance is uncovering antibodies that could harm a transfusion recipient.